| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8394426 | Toxicon | 2018 | 4 Pages |
Abstract
In this paper the authors debate the issue of whether treatment of CM with OnabotA should be standardized versus customized.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Mark W. Green, John F. Rothrock,